Fineline Cube

Follow:
14435 Articles
Dr. Noah Biotech Collaborates with Thermo Fisher to Accelerate Rare Disease Treatments
CompanyDeals

Dr. Noah Biotech Collaborates with Thermo Fisher to Accelerate Rare Disease Treatments

TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board
CompanyDeals

TenNor Therapeutics Submits Listing Application to Hong Kong Stock Exchange Main Board

FDA Clears Elevidys Gene Therapy After Investigating 8-Year-Old Boy's Death
CompanyDrug

FDA Clears Elevidys Gene Therapy After Investigating 8-Year-Old Boy’s Death

Mabwell's CDH17-Targeted ADC 7MW4911 Receives Clinical Trial Approval in China and IND Clearance in the US
CompanyDrug

Mabwell’s CDH17-Targeted ADC 7MW4911 Receives Clinical Trial Approval in China and IND Clearance in the US

Cutia Therapeutics' CU-40102 Approved in Hong Kong for Androgenetic Alopecia Treatment
CompanyDrug

Cutia Therapeutics’ CU-40102 Approved in Hong Kong for Androgenetic Alopecia Treatment

UTC Therapeutics Gains FDA Clearance for CAR-T Therapy UCLM805 in MSLN-Positive Solid Tumors
CompanyDrug

UTC Therapeutics Gains FDA Clearance for CAR-T Therapy UCLM805 in MSLN-Positive Solid Tumors

FDA Mandates Safety Labeling Changes for Opioid Pain Medications and Targets 7-OH Products
CompanyDrug

FDA Mandates Safety Labeling Changes for Opioid Pain Medications and Targets 7-OH Products

Luye Pharma’s LY03021 Completes Enrollment of First Healthy Subject in Phase I Trial
CompanyDrug

Luye Pharma’s LY03021 Completes Enrollment of First Healthy Subject in Phase I Trial

AllianThera Partners with Dr. Falk Pharma to Develop ATB102 for Ulcerative Colitis
CompanyDeals

AllianThera Partners with Dr. Falk Pharma to Develop ATB102 for Ulcerative Colitis

Grand Pharma Partners with IRE EliT to Distribute 68Ge/68Ga Generators in China
CompanyDeals

Grand Pharma Partners with IRE EliT to Distribute 68Ge/68Ga Generators in China

Lee's Pharma's Socazolimab Approved by NMPA for ES-SCLC First-Line Treatment
CompanyDrug

Lee’s Pharma’s Socazolimab Approved by NMPA for ES-SCLC First-Line Treatment

BrightGene and CR Sanjiu Collaborate on BGM0504 Injection Development and Commercialization
CompanyDeals

BrightGene and CR Sanjiu Collaborate on BGM0504 Injection Development and Commercialization